Statewide

Oklahoma State Department of Health

May be outdated182 dose entries33 drugs10 documentsOKeffective 2018-01-0194% machine-parsed of 182

Oklahoma State Department of Health (OK) carries 33 drugs across 182 dose entries in its current published protocol, effective 2018-01-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses33

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 mg	NEB	not captured	standing	pages 216, 285
Cyanide poisoning	peds	2.5 mg	NEB	not captured	standing	pages 216, 285
Other	adult	5 mg	NEB	not captured	standing	pages 50, 285
Other	adult	5 mg	NEB	not captured	standing	pages 51, 285
Other	adult	5 mg	NEB	not captured	standing	pages 52, 285
Other	adult	5 mg	NEB	not captured	standing	pages 151, 285
Other	adult	5 mg	NEB	not captured	standing	pages 153, 285
Other	peds	2.5 mg	NEB	not captured	standing	pages 50, 285
Other	peds	2.5 mg	NEB	not captured	standing	pages 51, 285
Other	peds	2.5 mg	NEB	not captured	standing	pages 151, 285
Other	peds	2.5 mg	NEB	not captured	standing	pages 153, 285

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 OR 325 mg	PO	not captured	standing	pages 95, 288
ACS / chest pain	adult	324 OR 325 mg	PO	not captured	standing	pages 100, 288

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5 mg	IV	not captured	standing	pages 101, 289
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 101, 289
Organophosphate poisoning	adult	2 mg	IV/IM	not captured	standing	pages 148, 289
Organophosphate poisoning	peds	0.05 mg/kg	IV/IM	not captured	standing	pages 148, 289

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	10 mg/kg	IV	not captured	standing	pages 89, 291
Beta-blocker / calcium-channel-blocker overdose	peds	10 mg/kg	IV	not captured	standing	pages 89, 291
Hyperkalemia	adult	10 mg/kg	IV	not captured	standing	pages 89, 160
Hyperkalemia	peds	10 mg/kg	IV	not captured	standing	pages 89, 160

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mL/kg	IV	not captured	standing	pages 49, 132, 137, 138, 139, 160
Hypoglycemia	peds	2 mL/kg	IV	not captured	standing	pages 49, 132, 137, 138, 139, 160

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV	not captured	standing	pages 144, 296
Agitation	peds	0.1 mg/kg (max 5 mg)	IV	not captured	standing	pages 144, 296
Agitation	peds	0.1 mg/kg (max 5 mg)	IM	not captured	standing	pages 144, 296
Dystonic reaction	adult	5 mg	IV	not captured	standing	pages 139, 296
Dystonic reaction	peds	0.1 mg/kg (max 5 mg)	IM	not captured	standing	pages 139, 296
Other	adult	0.1 mg/kg (max 5 mg)	IV	not captured	standing	page 36
Other	adult	10 mg	IM	not captured	standing	page 178
Other	adult	10 mg	IM	not captured	standing	pages 210, 296
Other	adult	2.5 mg	IV	not captured	standing	page 296
Other	adult	5 mg	IV	not captured	standing	page 178
Other	adult	5 mg	IV	not captured	standing	pages 210, 296
Other	peds	0.1 mg/kg (max 5 mg)	IV	not captured	standing	pages 210, 296
Other	peds	0.1 mg/kg (max 5 mg)	IM	not captured	standing	pages 210, 296
Seizure	adult	10 mg	IM	not captured	standing	pages 137, 139, 296
Seizure	adult	5 mg	IV	not captured	standing	pages 137, 139, 296
Seizure	peds	0.1 mg/kg (max 5 mg)	IV	not captured	standing	pages 137, 139, 296
Seizure	peds	0.1 mg/kg (max 5 mg)	IM	not captured	standing	pages 137, 139, 296

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Dystonic reaction	adult	50 mg	IV/IM	not captured	standing	pages 139, 298
Dystonic reaction	peds	1 mg/kg	IV/IM	not captured	standing	pages 139, 298
Other	adult	50 mg	IV/IM	not captured	standing	pages 151, 298
Other	adult	50 mg	IV/IM	not captured	standing	pages 153, 298
Other	peds	1 mg/kg	IV/IM	not captured	standing	pages 151, 298
Other	peds	1 mg/kg	IV/IM	not captured	standing	pages 153, 298

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–20 mcg/kg	IV/IO	not captured	standing	pages 299, 300

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 51, 303
Asthma / bronchospasm	peds	0.01 mg/kg (max 0.3 mg)	IM	not captured	standing	pages 51, 303
Bradycardia	peds	0.01 mg/kg	IV	not captured	standing	pages 101, 304
Cardiac arrest	adult	1 mg	IV	not captured	standing	pages 86, 87, 88, 304
Cardiac arrest	peds	0.01 mg/kg	IV	not captured	standing	pages 86, 87, 88, 304
Other	peds	0.01 mg/kg	IV	not captured	standing	pages 151, 152, 153, 304
Other	peds	0.01 mg/kg (max 0.3 mg)	IM	not captured	standing	pages 151, 152, 153, 303

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV	not captured	standing	pages 36, 307

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1 mcg/kg	IV/IM/IN	not captured	standing	pages 95, 156, 159, 179, 180, 181, 186, 191, 193, 205, 309
Mild to moderate pain	peds	1 mcg/kg	IV/IM/IN	not captured	standing	pages 95, 156, 159, 179, 180, 181, 186, 191, 193, 205, 309

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV	not captured	standing	pages 89, 311
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV	not captured	standing	pages 89, 311
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 49, 132, 137, 138, 139, 160, 311
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 49, 132, 137, 138, 139, 160, 311

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	pages 144, 314

Hydralazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IV	not captured	standing	pages 113, 315
Other	adult	10 mg	IV	not captured	standing	pages 113, 315

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.5–1 mg	IV	not captured	standing	page 317
Burns	adult	0.5–1 mg	IV	not captured	standing	page 317
Crush injury	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Other	adult	0.5–1 mg	IV	not captured	standing	page 317
Mild to moderate pain	adult	0.5–1 mg	IV	not captured	standing	page 317

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	not captured	not captured	standing	page 318
Cyanide poisoning	peds	70 mg/kg	not captured	not captured	standing	page 318

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mg	NEB	not captured	standing	pages 319, 320
Other	adult	0.5 mg	NEB	not captured	standing	page 319
Other	adult	0.5 mg	NEB	not captured	standing	pages 319, 320
Other	adult	0.5 mg	NEB	not captured	standing	pages 319, 320
Other	peds	0.25 mg	NEB	not captured	standing	pages 319, 320
Other	peds	0.25 mg	NEB	not captured	standing	pages 319, 320
Other	peds	0.25 mg	NEB	not captured	standing	pages 319, 320

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20 mg	IV	not captured	standing	page 321
Other	adult	20 mg	IV	not captured	standing	page 321
Other	peds	0.3 mg/kg	IV	not captured	standing	page 321

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mg/kg	IV	not captured	standing	page 324
Other	adult	1 mg/kg	not captured	not captured	standing	page 324
Other	peds	1 mg/kg	not captured	not captured	standing	page 324

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2 mg	IV/IM	not captured	standing	pages 144, 327
Agitation	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 144, 327
Dystonic reaction	adult	2 mg	IV/IM	not captured	standing	pages 139, 327
Dystonic reaction	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 139, 327
Other	adult	0.1 mg/kg	IV	not captured	standing	page 36
Other	adult	1–2 mg	IV/IM	not captured	standing	page 327
Other	adult	1 mg	IV/IM	not captured	standing	pages 178, 327
Other	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 178, 327
Seizure	adult	2 mg	IV/IM	not captured	standing	pages 137, 327
Seizure	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 137, 327

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV	not captured	standing	pages 87, 328
Other	adult	1 g	IV	not captured	standing	pages 105, 328
Other	adult	1 g	IV	not captured	standing	pages 224, 328
Other	adult	2 g	IV	not captured	standing	pages 51, 328

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	125 mg	IV/IM	not captured	standing	pages 51, 330
Other	adult	125 mg	IV/IM	not captured	standing	pages 52, 330
Other	adult	125 mg	IV/IM	not captured	standing	pages 151, 330
Other	adult	125 mg	IV/IM	not captured	standing	pages 153, 330
Other	peds	2 mg/kg	IV/IM	not captured	standing	pages 51, 330
Other	peds	2 mg/kg	IV/IM	not captured	standing	pages 151, 330
Other	peds	2 mg/kg	IV/IM	not captured	standing	pages 153, 330

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 144, 332
Agitation	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 144, 332
Dystonic reaction	adult	2.5 mg	IV/IM/IN	not captured	standing	pages 139, 332
Dystonic reaction	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 139, 332
Other	adult	0.1 mg/kg	IV	not captured	standing	pages 36, 331
Other	adult	0.1 mg/kg	IV	not captured	standing	pages 90, 331
Other	adult	0.1 mg/kg	IV	not captured	standing	pages 106, 332
Other	adult	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 148, 332
Other	adult	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 210, 332
Other	adult	2–5 mg	IV	not captured	standing	pages 102, 331
Other	adult	5 mg	IV/IM/IN	not captured	standing	pages 178, 332
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 90, 331
Other	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 178, 332
Other	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 210, 332
Seizure	adult	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 137, 332
Seizure	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 137, 332

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2–4 mg	IV	not captured	standing	pages 100, 334
Burns	adult	2–4 mg	IV	not captured	standing	pages 193, 334
Crush injury	adult	2–4 mg	IV	not captured	standing	pages 192, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 159, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 95, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 152, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 156, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 180, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 181, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 186, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 191, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 212, 334
Other	adult	2–4 mg	IV	not captured	standing	pages 227, 334
Mild to moderate pain	adult	2–4 mg	IV	not captured	standing	pages 179, 334

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	0.5 mg	IV/IN	not captured	standing	pages 49, 335, 336
Other	peds	0.5 mg	IV/IN	not captured	standing	pages 89, 335, 336
Other	peds	0.5 mg	IV/IN	not captured	standing	pages 132, 335, 336
Other	peds	0.5 mg	IV/IN	not captured	standing	pages 138, 335, 336
Other	peds	0.5 mg	IV/IN	not captured	standing	pages 148, 335, 336

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	2.1 mg	IM	not captured	standing	page 302
Nerve agent exposure	peds	0.05 mg/kg	IM	not captured	standing	page 302

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 100, 338
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 53, 338
Other	adult	0.4 mg	SL	not captured	standing	pages 95, 338
Other	adult	0.4 mg	SL	not captured	standing	pages 113, 338
Other	adult	0.4 mg	SL	not captured	standing	pages 226, 338

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–4 mcg	not captured	not captured	standing	pages 53, 339
Other	adult	2–4 mcg	not captured	not captured	standing	pages 90, 339
Other	adult	2–4 mcg	not captured	not captured	standing	pages 100, 339
Other	adult	2–4 mcg	not captured	not captured	standing	pages 157, 339
Other	adult	2–4 mcg	not captured	not captured	standing	pages 160, 339

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	4 mg	IV/ODT	not captured	standing	pages 157, 341
Fever	peds	0.1 mg/kg	IV/ODT	not captured	standing	pages 157, 341
Other	adult	4 mg	IV/ODT	not captured	standing	pages 152, 341
Other	adult	4 mg	IV/ODT	not captured	standing	pages 156, 341
Other	adult	4 mg	IV/ODT	not captured	standing	pages 227, 341
Other	peds	0.1 mg/kg	IV/ODT	not captured	standing	pages 152, 341
Other	peds	0.1 mg/kg	IV/ODT	not captured	standing	pages 156, 341
Other	peds	0.1 mg/kg	IV/ODT	not captured	standing	pages 227, 341

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO/SL	not captured	standing	pages 132, 138, 139, 160, 312, 313
Hypoglycemia	peds	7.5 g	PO/SL	not captured	standing	pages 132, 138, 139, 160, 312, 313

Phenylephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–4 spray	IN	not captured	standing	pages 158, 344
Other	peds	2–4 spray	IN	not captured	standing	pages 158, 344
RSI induction	adult	2 spray	IN	not captured	standing	pages 37, 344

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	600 mg	IM	not captured	standing	pages 148, 345
Organophosphate poisoning	peds	15 mg/kg	IM	not captured	standing	pages 148, 345

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 mEq/kg	IV	not captured	standing	pages 89, 346
Hyperkalemia	peds	1 mEq/kg	IV	not captured	standing	pages 89, 346
Other	adult	1 mEq/kg	IV	not captured	standing	pages 89, 346
Other	peds	1 mEq/kg	IV	not captured	standing	pages 89, 346
Tricyclic overdose	adult	1 mEq/kg	IV	not captured	standing	pages 148, 346
Tricyclic overdose	peds	1 mEq/kg	IV	not captured	standing	pages 148, 346

Cite this

Oklahoma State Department of Health, United States EMS Protocol Census. 182 dose entries, effective 2018-01-01.

https://protoquiz.com/census/agencies/oklahoma-state-department-of-health/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.